Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neoplasms × temsirolimus × Clear all

Phase

Phase 1 6 Phase 2 4 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Solid Tumor 1 Neoplasms 1 Glioma 1 Glioblastoma 1

Interventions

Cyclophosphamide 4 Positron Emission Tomography Computed Tomography 3 pembrolizumab 2 Psilocybin 2 Midazolam 2 Methods 2 Ketamine 2 temsirolimus 1 posaconazole 1 poly ICLC 1 parathyroid hormone-related peptide (1-36) 1 lavender oil 1 jojoba wax 1 ginger extract 1 fludarabine phosphate 1 fludarabine 1 fluciclovine F-18 1 evolocumab 1 beta-Glucans 1 Whole-Body Irradiation 1 Varenicline 1 Transplantation 1 Topotecan 1 Tetrahydrouridine 1 Temozolomide 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Sodium Chloride 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01417065 2014-06-23

Temsirolimus In Phase 0

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡